Zobrazeno 1 - 10
of 77
pro vyhledávání: '"M. Pitlick"'
Autor:
Jacqueline D. Squire, MD, Mitchell M. Pitlick, MD, Catherine M. Freeman, MB, BCh, Avni Y. Joshi, MD, MS
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100081- (2023)
Background: The past 2 years of the COVID-19 pandemic brought with it many unknowns for patients with immunodeficiency. Because of the concern for severe infection in those with immunocompromise, patients have been eager for effective prevention, vac
Externí odkaz:
https://doaj.org/article/908d740bacaf4bba9f178af63bb6389c
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 11, Pp 100707- (2022)
The indications for biologic therapy are expanding. Patients may benefit from different biologics for separate conditions or one condition with multiple pathogenic mechanisms targeted by different biologics. We sought to determine the frequency and s
Externí odkaz:
https://doaj.org/article/dcb084c90bd44ae89c4c1ba09a1b914f
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 8, Pp 100676- (2022)
Eosinophilic disorders include a wide array of conditions in which eosinophils play a primary pathophysiologic role. While historically treated with corticosteroids and immunosuppressants, knowledge of eosinophil biology has led to the development of
Externí odkaz:
https://doaj.org/article/068b21f1aa104bcc92bb4558f2c99e9f
Autor:
Mitchell M. Pitlick, MD, Daenielle K. Lang, MD, Anne M. Meehan, MBBCh, PhD, Christopher P. McCoy, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 682-687 (2021)
E-cigarette or vaping product use–associated lung injury (EVALI) is a respiratory illness that has significant overlap with the symptoms of coronavirus disease 2019 (COVID-19). In the current pandemic, diagnosis of EVALI may be delayed because of a
Externí odkaz:
https://doaj.org/article/a5cdf7c572cc4358870f7cdd764e819d
Publikováno v:
Immunology and Allergy Clinics of North America. 42:145-159
Perioperative anaphylaxis is a potentially life-threatening and under-recognized event most commonly caused by antibiotics, neuromuscular blocking agents, dyes, latex, and disinfectants. This review provides updates in the epidemiology and pathogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a378457aa57ae248be2bad472335d06
https://doi.org/10.1016/j.iac.2021.09.002
https://doi.org/10.1016/j.iac.2021.09.002
Autor:
Mitchell M. Pitlick, Miguel A. Park, Alexei Gonzalez-Estrada, Kelley N. Dages, Michael D'Netto, Andrea N. Sitek, Avni Y. Joshi, Sergio E. Chiarella
Publikováno v:
Annals of Allergy, Asthma & Immunology
Background The mechanism of coronavirus disease 2019 (COVID-19) vaccine hypersensitivity reactions is unknown. COVID-19 vaccine excipient skin testing has been used in evaluation of these reactions, but its utility in predicting subsequent COVID-19 v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f0c7c645dd89f2e87a7c90ce840340
https://doi.org/10.1016/j.anai.2021.11.006
https://doi.org/10.1016/j.anai.2021.11.006
Publikováno v:
Allergy Asthma Proc
Background: As the vaccination campaign in response to the coronavirus disease 2019 (COVID-19) pandemic continues, concerns with regard to adverse reactions to the vaccine remain. Although immediate hypersensitivity reactions have received much atten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b763b35a9c42ae0aedbeb234f797072
https://doi.org/10.2500/aap.2022.43.210101
https://doi.org/10.2500/aap.2022.43.210101
Publikováno v:
Annals of Allergy, Asthma & Immunology. 128:731-733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3218cd795e53bb48a79d0fa8bacc09
https://doi.org/10.1016/j.anai.2022.02.024
https://doi.org/10.1016/j.anai.2022.02.024
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 79(23)
Purpose Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of beta cells, resulting in a loss of insulin production. Patients with T1D carry a substantial disease burden as well as substantial short-term and long-term ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c7e1665c85eedb29bf37d4b48ba3ad
https://pubmed.ncbi.nlm.nih.gov/36056809
https://pubmed.ncbi.nlm.nih.gov/36056809
Autor:
Rohit Divekar, Avni Y. Joshi, Vivek N. Iyer, Zhen Wang, Mitchell M. Pitlick, Justine M. Ade, Andrea N. Sitek, Sergio E. Chiarella
Publikováno v:
Allergy and Asthma Proceedings. 42:267-273
Background: It remains unclear if asthma is a risk factor associated with worse outcomes among patients with coronavirus disease 2019 (COVID-19). Methods: We performed a comprehensive database search for studies published from January 1, 2019, to Oct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73644d9923ed0fb5e17f9f44c9aa47d
https://doi.org/10.2500/aap.2021.42.210041
https://doi.org/10.2500/aap.2021.42.210041